Keros Therapeutics, Inc.
KROS
$15.52
$0.614.09%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 70.06% | 62.86% | 69.09% | 84.33% | 26.03% |
| Total Receivables | 1,218.88% | 989.65% | 308.43% | 114.14% | 39.52% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 96.29% | 3.65% | 5.93% | -5.71% | 14.81% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -14.89% | 3.64% | 69.70% | 30.01% | 156.14% |
| Total Current Assets | 69.35% | 64.00% | 69.57% | 81.33% | 29.44% |
|
|
|||||
| Total Current Assets | 69.35% | 64.00% | 69.57% | 81.33% | 29.44% |
| Net Property, Plant & Equipment | 20.94% | 19.10% | 20.65% | 27.14% | -0.82% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -56.96% | -41.42% | 7.38% | 8.97% | 16.06% |
| Total Assets | 66.40% | 61.49% | 66.44% | 77.56% | 27.71% |
|
|
|||||
| Total Accounts Payable | -19.40% | 33.09% | -15.56% | 28.81% | 57.62% |
| Total Accrued Expenses | 49.19% | 41.69% | 18.55% | 85.03% | 14.14% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 103.47% | 100.19% | 96.82% | 203.93% | -- |
| Total Finance Division Other Current Liabilities | 1,529.83% | 1,523.74% | -37.44% | -18.24% | 8.37% |
| Total Other Current Liabilities | 1,529.83% | 1,523.74% | -37.44% | -18.24% | 8.37% |
| Total Current Liabilities | 63.37% | 110.38% | 12.62% | 73.68% | 32.00% |
|
|
|||||
| Total Current Liabilities | 63.37% | 110.38% | 12.62% | 73.68% | 32.00% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 22.26% | 24.00% | 25.63% | 27.18% | -7.81% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 47.87% | 74.73% | 17.25% | 52.72% | 13.51% |
|
|
|||||
| Common Stock & APIC | 29.98% | 30.82% | 59.79% | 65.71% | 41.83% |
| Retained Earnings | 4.00% | 0.99% | -49.12% | -53.22% | -55.69% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 67.90% | 60.56% | 72.04% | 80.11% | 29.01% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 67.90% | 60.56% | 72.04% | 80.11% | 29.01% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 67.90% | 60.56% | 72.04% | 80.11% | 29.01% |
|
|
|||||